With increasing evidence of PD-L1 expression from cervical intraepithelial neoplasia to metastatic disease, immunotherapy (with or without additional systemic or local therapy) may potentially have a therapeutic role across several stages of cervical cancer. This evidence concerns the gene CD274 and cervical intraepithelial neoplasia.